Literature DB >> 21221805

Self dilation as a treatment for resistant benign esophageal strictures: outcome, technique, and quality of life assessment.

Ivana Dzeletovic1, David E Fleischer, Michael D Crowell, Hack J Kim, Lucinda A Harris, George E Burdick, Roxane R McLaughlin, Robert V Spratley, Virender K Sharma.   

Abstract

BACKGROUND: Resistant benign esophageal strictures can have a negative impact on patients' quality of life. A portion of these patients require frequent physician performed dilations, leading to numerous interactions with their attendant inconvenience and sense of dependence. This study demonstrates the efficacy, safety and effect on quality of life of this under-utilized technique.
METHODS: A retrospective chart review was performed for all patients undergoing esophageal self dilation at our institution between January 2003 and November 2009. The impact on quality of life was evaluated using a telephone questionnaire specifically designed to explore emotional, social and financial impacts.
RESULTS: Of the 11 patients who initially began self dilation for non-malignant strictures, nine are included in this study. Median follow-up was 35.4 months (range 6-168). No significant complications were reported. When asked to compare self dilation with physician performed dilation a large proportion of patients reported financial benefits, and a majority reported being more socially active. Overall quality of life improvement was reported by almost all of the participants in the study. Global scores for dysphagia and overall quality of life were significantly improved under conditions of self dilation versus physician performed dilation (P = 0.008 and P = 0.016, respectively).
CONCLUSIONS: Our results suggest that esophageal self dilation can be a safe and effective treatment modality in motivated patients with benign resistant esophageal strictures. Esophageal self dilation has a positive impact on emotional, social, and financial aspects of patient's life. Self dilation should be considered a treatment option in all patients with benign resistant esophageal strictures.

Entities:  

Mesh:

Year:  2011        PMID: 21221805     DOI: 10.1007/s10620-010-1503-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  Self-dilation for resistant, benign esophageal strictures.

Authors:  Ivana Dzeletovic; David E Fleischer
Journal:  Am J Gastroenterol       Date:  2010-10       Impact factor: 10.864

2.  Oesophageal self-bougienage.

Authors:  I T Gilmore; R Sheers
Journal:  Lancet       Date:  1982-03-13       Impact factor: 79.321

3.  Prospective randomized comparison of polyvinyl bougies and through-the-scope balloons for dilation of peptic strictures of the esophagus.

Authors:  Z A Saeed; C B Winchester; P S Ferro; P A Michaletz; J T Schwartz; D Y Graham
Journal:  Gastrointest Endosc       Date:  1995-03       Impact factor: 9.427

4.  Self-bougienage in the treatment of benign esophageal stricture.

Authors:  J L Grobe; R A Kozarek; R A Sanowski
Journal:  J Clin Gastroenterol       Date:  1984-04       Impact factor: 3.062

5.  Natural history of benign esophageal stricture treated by dilatation.

Authors:  D J Patterson; D Y Graham; J L Smith; J T Schwartz; E Alpert; F L Lanza; G D Cain
Journal:  Gastroenterology       Date:  1983-08       Impact factor: 22.682

6.  Bougienage is effective therapy for most benign esophageal strictures.

Authors:  F L Lanza; D Y Graham
Journal:  JAMA       Date:  1978-09-01       Impact factor: 56.272

7.  The requirement for esophageal bougienage.

Authors:  E D Palmer
Journal:  GP       Date:  1966-04

8.  Factors influencing clinical applications of endoscopic balloon dilation for benign esophageal strictures.

Authors:  Y-C Chiu; C-C Hsu; K-W Chiu; S-K Chuah; C-S Changchien; K-L Wu; Y-P Chou
Journal:  Endoscopy       Date:  2004-07       Impact factor: 10.093

9.  The Mayo Dysphagia Questionnaire-30: documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease.

Authors:  Judith McElhiney; Matthew R Lohse; Amindra S Arora; Joanna M Peloquin; Debra M Geno; Melissa M Kuntz; Felicity B Enders; Mary Fredericksen; Adil A Abdalla; Yulia Khan; Nicholas J Talley; Nancy N Diehl; Timothy J Beebe; Ann M Harris; Gianrico Farrugia; Darlene E Graner; Joseph A Murray; G Richard Locke; Rayna M Grothe; Michael D Crowell; Dawn L Francis; April M B Grudell; Tushar Dabade; Angelica Ramirez; MhdMaan Alkhatib; Jeffrey A Alexander; Jessica Kimber; Ganapathy Prasad; Alan R Zinsmeister; Yvonne Romero
Journal:  Dysphagia       Date:  2009-10-24       Impact factor: 3.438

10.  Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis.

Authors:  R D Marks; J E Richter; J Rizzo; R E Koehler; J G Spenney; T P Mills; G Champion
Journal:  Gastroenterology       Date:  1994-04       Impact factor: 22.682

View more
  5 in total

1.  TNF-related apoptosis-inducing ligand (TRAIL) regulates midline-1, thymic stromal lymphopoietin, inflammation, and remodeling in experimental eosinophilic esophagitis.

Authors:  Adam M Collison; Leon A Sokulsky; Joseph D Sherrill; Scott Nightingale; Luke Hatchwell; Nicholas J Talley; Marjorie M Walker; Marc E Rothenberg; Joerg Mattes
Journal:  J Allergy Clin Immunol       Date:  2015-05-13       Impact factor: 10.793

2.  Self-dilation as a treatment for resistant, benign esophageal strictures.

Authors:  Ivana Dzeletovic; David E Fleischer; Michael D Crowell; Rahul Pannala; Lucinda A Harris; Francisco C Ramirez; George E Burdick; Lauri A Rentz; Robert V Spratley; Susan D Helling; Jeffrey A Alexander
Journal:  Dig Dis Sci       Date:  2013-08-08       Impact factor: 3.199

Review 3.  Recurrent esophageal stricture from previous caustic ingestion treated with 40-year self-dilation: case report and review of literature.

Authors:  C Gambardella; A Allaria; G Siciliano; C Mauriello; R Patrone; N Avenia; A Polistena; A Sanguinetti; S Napolitano; G Conzo
Journal:  BMC Gastroenterol       Date:  2018-05-22       Impact factor: 3.067

4.  UK guidelines on oesophageal dilatation in clinical practice.

Authors:  Sarmed S Sami; Hasan N Haboubi; Yeng Ang; Philip Boger; Pradeep Bhandari; John de Caestecker; Helen Griffiths; Rehan Haidry; Hans-Ulrich Laasch; Praful Patel; Stuart Paterson; Krish Ragunath; Peter Watson; Peter D Siersema; Stephen E Attwood
Journal:  Gut       Date:  2018-02-24       Impact factor: 23.059

5.  Self-dilation for therapy-resistant benign esophageal strictures: towards a systematic approach.

Authors:  Emo E van Halsema; Chantal A 't Hoen; Patricia S de Koning; Wilda D Rosmolen; Jeanin E van Hooft; Jacques J Bergman
Journal:  Surg Endosc       Date:  2018-01-18       Impact factor: 4.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.